EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

GMI, a Fungal Immunomodulatory Protein From Ganoderma microsporum , Induces Different Cytotoxicity in Parental and Osimertinib‐Resistant EGFR‐Mutated Lung Cancer Cells via Apoptotic and Autophagic Cell Death

Yu-Ting Kang, I-Lun Hsin, Pin-Tzu Su, Ya-Chu Hsieh, Hui-Yi Chang, Jiunn-Liang Ko iD, Jen-Ning Tsai

Basic & Clinical Pharmacology & Toxicology · 2025-12 · 137 (6)

DOI: 10.1111/bcpt.70143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, online erschienen am 21.11.2025. Verfasst von Yu-Ting Kang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan. Hauptthemen laut MEDLINE: Lung Neoplasms, Ganoderma, Fungal Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science and Technology Council, Taiwan National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung adenocarcinoma often carries driver mutations, such as EGFR mutations, which are effectively targeted by EGFR tyrosine kinase inhibitors (EGFR‐TKIs) like osimertinib, a third‐generation EGFR‐TKI approved for treating T790M and other EGFR‐activating mutations. However, the development of adaptive drug resistance remains a major challenge and is associated with poor prognosis in cancer therapy. Ganoderma microsporum immunomodulatory protein (GMI) has demonstrated anticancer properties in various cancers and exhibits synergistic cytotoxic effects when combined with several anticancer drugs. This study investigated the cytotoxic mechanisms of GMI on the lung cancer cell line H1975, which harbors the EGFR L858R/T790M double mutation, as well as on H1975/TR cells with osimertinib resistance. GMI treatment triggered apoptosis in H1975 cells, as indicated by plasma membrane phospholipid translocation and loss of mitochondrial membrane potential. GMI‐treated cells displayed increased LC3BII and the development of acidic vesicular organelles, both of which are hallmarks of autophagy induction. Autophagy inhibition by 3‐methyladenine and ATG gene silencing effectively decreased the cytotoxic effect of GMI, suggesting that GMI induces autophagic cell death in H1975/TR cells. This study is the first to reveal the novel role of GMI in inducing cytotoxic effects in H1975 cells and H1975/TR cells with osimertinib resistance through two different forms of cell death: apoptosis and autophagy, respectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsGanodermaFungal ProteinsHumansDrug Resistance, NeoplasmApoptosisAniline CompoundsCell Line, TumorAutophagyErbB ReceptorsAcrylamidesMutationMembrane Potential, MitochondrialAntineoplastic AgentsProtein Kinase InhibitorsAdenocarcinoma of LungIndolesPyrimidines

Stichwörter der Autor:innen

EGFR mutantGMIapoptosisautophagylung cancerosimertinib‐resistance

Substanzen

osimertinibAniline CompoundsErbB ReceptorsAcrylamidesEGFR protein, humanFungal ProteinsAntineoplastic AgentsProtein Kinase InhibitorsIndolesPyrimidines

Autor:innen und Institutionen

  • Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
  • Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Department of Nursing, National Taichung University of Science and Technology, Taichung, Taiwan.
  • Institute and Department of Food Science, Central Taiwan University of Science and Technology, Taichung, Taiwan.
  • Department of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung, Taiwan.
  • Department of Internal Medicine, Division of Medical Oncology, Chung Shan Medical University Hospital, Taichung, Taiwan.

ORCID-Profile: Jiunn-Liang Ko

Förderung

  • National Science and Technology Council
  • Taiwan National Science and Technology Council

Zitieren

APA

Kang, Y. T., Hsin, I. L., Su, P. T., Hsieh, Y. C., Chang, H. Y., Ko, J. L., & Tsai, J. N. (2025). GMI, a Fungal Immunomodulatory Protein From Ganoderma microsporum , Induces Different Cytotoxicity in Parental and Osimertinib‐Resistant EGFR‐Mutated Lung Cancer Cells via Apoptotic and Autophagic Cell Death. Basic & Clinical Pharmacology & Toxicology, 137(6). https://doi.org/10.1111/bcpt.70143

Vancouver

Kang YT, Hsin IL, Su PT, Hsieh YC, Chang HY, Ko JL, et al. GMI, a Fungal Immunomodulatory Protein From Ganoderma microsporum , Induces Different Cytotoxicity in Parental and Osimertinib‐Resistant EGFR‐Mutated Lung Cancer Cells via Apoptotic and Autophagic Cell Death. Basic & Clinical Pharmacology & Toxicology. 2025;137(6). doi:10.1111/bcpt.70143

BibTeX
@article{Kang2025,
  author = {Kang, Yu-Ting and Hsin, I-Lun and Su, Pin-Tzu and Hsieh, Ya-Chu and Chang, Hui-Yi and Ko, Jiunn-Liang and Tsai, Jen-Ning},
  title = {GMI, a Fungal Immunomodulatory Protein From Ganoderma microsporum , Induces Different Cytotoxicity in Parental and Osimertinib‐Resistant EGFR‐Mutated Lung Cancer Cells via Apoptotic and Autophagic Cell Death},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2025},
  volume = {137},
  number = {6},
  doi = {10.1111/bcpt.70143}
}
Kostenlos starten →